Groowe Groowe / Newsroom / SNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNY News

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX

businesswire.com
DVAX SNY

Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX

businesswire.com
DVAX SNY

Honoring 45 Organ, Eye and Tissue Donors, Living Donors and Recipients: The 2026 OneLegacy Donate Life Rose Parade® Float Celebrates 23 Years of Participation in the Iconic Rose Parade®

businesswire.com
SNY

Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline

globenewswire.com
SNY DVAX

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

globenewswire.com
SNY

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia

globenewswire.com
SNY

Local Organ, Eye and Tissue Donors, Transplant Recipients and Living Donors to be Honored on the 2026 OneLegacy Donate Life Rose Parade® Float on New Year’s Day

businesswire.com
SNY

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

globenewswire.com
REGN SNY

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma

globenewswire.com
REGN SNY

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

globenewswire.com
SNY